H. Brodt

G. Ippolito, P. Brouqui, H. Brodt, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Listeria monocytogenes/Listeriose

H. Brodt, J. Stein, 2006 .

Combined plasmapheresis and immunosuppression as rescue treatment of a patient with catastrophic antiphospholipid syndrome occurring despite anticoagulation: a case report.

H. Brodt, S. Koschmieder, W. Miesbach, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Immune Response after a Single Dose of the 2010/11 Trivalent, Seasonal Influenza Vaccine in HIV-1–Infected Patients and Healthy Controls

M. Bickel, H. Doerr, H. Brodt, 2013, HIV clinical trials.

Impact of Stereotactic Biopsy in HIV Patients.

H. Brodt, V. Seifert, G. Marquardt, 2016, World neurosurgery.

Management of microbiological samples in a confirmed case of 1 Ebola Virus Disease : Constraints and limitations 2 3-Guest Commentary ( revised JCM 01142-15 )-4 5

M. Hogardt, H. Brodt, K. Zacharowski, 2015 .

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients

M. Bickel, H. Doerr, H. Brodt, 2010, AIDS (London).

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

M. Bickel, H. Doerr, H. Brodt, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Inhibition of TNF-alpha mediated cell death by HIV-1 specific protease inhibitors.

H. Brodt, E. Helm, T. Wolf, 2003, European journal of medical research.

Noroviren (Norwalk- und Norwalk-like-Infektion)

H. Brodt, W. Caspary, 2006 .

Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patients

M. Bickel, H. Doerr, H. Brodt, 2014, Scandinavian journal of infectious diseases.

A curriculum for training healthcare workers in the management of highly infectious diseases.

G. Ippolito, H. Brodt, R. Gottschalk, 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Gastrointestinale Manifestationen der HIV-Infektion

H. Brodt, 2006 .

Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection.

H. Brodt, P. Gute, E. Herrmann, 2015, Virology.

Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).

J. Sterne, A. Mocroft, A. d’Arminio Monforte, 2014, International journal of epidemiology.

Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy

M. Bickel, A. Berger, H. Brodt, 2013, Medical Microbiology and Immunology.

Markus Bickel, Robert M. Grant, Peter Bacchetti, 2002, Journal of acquired immune deficiency syndromes.

Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival

H. Brodt, B. Kamps, E. Helm, 1998, AIDS.

Proton 1H- and Phosphorus 31P-MR spectroscopy (MRS) in asymptomatic HIV-positive patients

M. Bickel, E. Hattingen, H. Brodt, 2014, Journal of the International AIDS Society.

Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries

G. Ippolito, P. Brouqui, H. Brodt, 2009, Journal of Hospital Infection.

Trypanosoma brucei rhodesiense infection in a German traveller returning from the Masai Mara area, Kenya, January 2012.

H. Brodt, T. Wichelhaus, T. Wolf, 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)

H. Brodt, E. Helm, S. Fichtlscherer, 2005, Leukemia & lymphoma.

Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's disease

H. Stellbrink, H. Brodt, E. Wolf, 2004, British journal of haematology.

Proposed World-Health-Organization Staging System for Hiv-Infection and Disease - Preliminary Testing by An International Collaborative Cross-Sectional Study

J. Mills, R. Redfield, M. Maj, 1992 .

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir.

M. Kurowski, M. Bickel, M. Vogel, 2010, The Journal of antimicrobial chemotherapy.

Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma

H. Brodt, M. Hansmann, S. Newrzela, 2013, Modern Pathology.

A Case of Severe CMV-colitis in an HIV Positive Patient Despite Moderate Immunodeficiency

C. Fellbaum, M. Bickel, H. Brodt, 2003, Scandinavian Journal of Infectious Diseases.

European concepts for the domestic transport of highly infectious patients.

H. Brodt, A. Tegnell, V. Puro, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A randomized pilot study of triple nucleotide reverse transcriptase inhibitors therapy with tenofovir, zidovudine (AZT) plus emtricitabine in antiretroviral naive HIV-1 infected patients - The TEAZE study

S. Staszewski, M. Bickel, H. Brodt, 2010 .

Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country

S. Staszewski, H. Brodt, C. Stephan, 2008, AIDS.

Electron microscopy in diagnostics of SARS case

H. Klenk, H. Brodt, L. Kolesnikova, 2003, Microscopy and Microanalysis.

Is there really a correlation between AIDS dementia and Kaposi's sarcoma?

W. Schlote, H. Brodt, J. Neuenburg, 2000, AIDS.

Comparison of Drug Resistance Scores for Tipranavir in Protease Inhibitor-Naïve Patients Infected with HIV-1 B and Non-B Subtypes

M. Bickel, H. Doerr, H. Brodt, 2011, Antimicrobial Agents and Chemotherapy.

Winterbottom's Sign and Hypertrophic Cardiomyopathy

H. Brodt, S. Fichtlscherer, C. Stephan, 2002, Scandinavian journal of infectious diseases.

Rapid regression of Kaposi’s sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy

H. Brodt, C. Stephan, G. Schüttfort, 2016, Infection.

Behandlungseinrichtungen für hochkontagiöse, lebensbedrohliche Erkrankungen

H. Brodt, S. Schilling, H. Brodt, 2015, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations

F. Strle, H. Brodt, A. Horban, 2015, Clinical Microbiology and Infection.